Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse. - Wikidata - awgldk - TriplyDB

Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.

Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.

http://www.wikidata.org/entity/Q34223872

about

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy Interleukin-15 in the treatment of cancer.IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.N-glycan engineering of a plant-produced anti-CD20-hIL-2 immunocytokine significantly enhances its effector functions.Combination therapy with the type II anti-CD20 antibody obinutuzumab.Preparation of clinical-scale 177 Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulation.The potential and promise of IL-15 in immuno-oncogenic therapies.

P2860

Q26797345-B261BD2B-1E94-49B6-8990-C2048053CC81 Q28088784-5A7A1D84-A40C-4B1B-BAF5-12C08556FB1F Q38264072-F999E801-044F-4CEF-99DD-FCAEA4C71DF5 Q38768952-C6892753-40BE-4C4D-9F5F-6012F6702E5D Q38807514-904B228F-C8E9-468E-AB30-210FB3877EE1 Q47311471-88A9C246-A0E0-41C6-B8F4-BDE49DBB378E Q47898168-5DC7F92C-98D1-44F6-8D10-BA2E3A97F2F5 Q48258781-4A8EBC78-6415-44A8-9AC8-4C1FCCB460F5 Q49216382-89122324-4AC3-4907-A18C-2BF5635EE8F3

P2860

Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.

http://www.wikidata.org/entity/Q34223872

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@ast

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@en

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@nl

type

label

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@ast

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@en

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@nl

prefLabel

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@ast

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@en

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@nl

P1433

Q34223872-C90CC5D4-9ABC-4CBB-A678-2543F82FAC75

P1476

Q34223872-55CBBCCF-FF19-4752-BAE9-9F74D25B2205

P2093

Q34223872-25182EA4-9F87-4CEF-A33D-DABAF7E045C3

Q34223872-2AC3360A-40D9-4955-BE27-CEED58ED3F3B

Q34223872-3D4F432B-7441-4973-A052-44DEDC666636

Q34223872-49DEBB8F-9E98-4796-A4F2-33F1149250F0

Q34223872-5E9D6879-5631-4C39-95FC-5F411B9B8CD8

Q34223872-703C4A37-ACC7-4285-9F91-21F662B96809

Q34223872-7CD11152-CAAA-43A5-859B-F43DB8952555

Q34223872-85FD47D9-4BB3-414D-ABF0-343CE95D4D0B

Q34223872-B5B77CE4-3F1C-4FE3-8908-B3EDB40F610C

Q34223872-C95F986E-93E5-4E11-8BCE-CFC744555166

P2860

Q34223872-00B4E70F-93E3-4362-A171-EB068DF19C19

Q34223872-01109A62-0A05-4488-9503-9DD172F004F1

Q34223872-0E33DE48-EFA1-4C3A-98F4-CB6B8FA0F5E4

Q34223872-224588B5-3537-4CC6-9171-15B4AA571636

Q34223872-293C4E71-1EF4-454A-BADC-DFEF8ACBC688

Q34223872-2F716280-983C-488F-8845-55211D8C2E08

Q34223872-38EB4DB2-1CAC-453E-B35D-BCCEEF04C506

Q34223872-39E031FC-26D4-4B76-90CD-A1D3E32D54AD

Q34223872-3F4711B4-9D2C-42EB-9B57-EC9A6E60A0F7

Q34223872-4298846D-5AC9-4DF2-88BA-8BB7955110C8

P304

Q34223872-1956E4D5-26E7-4463-8FAB-58D51912E21C

P31

Q34223872-CC08B937-BCC4-4BE0-AE2F-ACDB994D36ED

P356

Q34223872-4CFB2C5B-6DE8-476E-997B-A6862194FD6B

P433

Q34223872-F4C4C438-283A-4ACA-884A-B80ADDBDF345

P478

Q34223872-0CF21BC2-7733-4412-A39F-932F60DF8093

P50

Q34223872-88424811-76DF-4955-9610-4491C18AC288

Q34223872-9B0F1A0F-BC89-4AA0-858E-B210876DF7B8

P577

Q34223872-747C4658-1447-423A-93EC-B0640893C959

P5875

Q34223872-1AEBBE8D-D15B-4F65-A43B-1D23ECCDB737

P698

Q34223872-D5370B3B-93AB-4FDF-B5AE-B92659A987F4

P932

Q34223872-3DEC31E8-A446-4D62-A5A1-9E2B82ED1A2B

P356

P1433

Monoclonal Antibodies

P1476

Highly potent anti-CD20-RLI im ...... uman B lymphoma in SCID mouse.

@en

P2093

Anne Bessard

http://www.w3.org/2001/XMLSchema#string

Béatrice Clémenceau

http://www.w3.org/2001/XMLSchema#string

David Béchard

http://www.w3.org/2001/XMLSchema#string

Gilles Thibault

http://www.w3.org/2001/XMLSchema#string

Géraldine Teppaz

http://www.w3.org/2001/XMLSchema#string

Laurie Lajoie

http://www.w3.org/2001/XMLSchema#string

Marie Vincent

http://www.w3.org/2001/XMLSchema#string

Mike Maillasson

http://www.w3.org/2001/XMLSchema#string

Séverine Loisel

http://www.w3.org/2001/XMLSchema#string

Véronique Solé

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins

Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes

Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes.

New insights into the regulation of T cells by gamma(c) family cytokines

Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions

P304

1026-1037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.28699

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Laure Garrigue-antar

Agnès Quéméner

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264315016

http://www.w3.org/2001/XMLSchema#string

P698

25072059

http://www.w3.org/2001/XMLSchema#string

P932

4171006

http://www.w3.org/2001/XMLSchema#string